Healio

Secondary SLT reduces medication load in eyes well controlled by drops

Please provide your email address to receive an email when new articles are posted on . Eyes that switched from eye drops to SLT had a significant reduction in the average number of medications. Eyes ...
MedPage Today

Laser Trabeculoplasty Tops Eye Drops as Frontline Treatment for Glaucoma

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...
The American Journal of Managed Care

Improving Glaucoma Outcomes With New Technologies and Patient-Centered Care

SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...
Healio

DSLT democratizes access to first-line laser for glaucoma, ocular hypertension

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
Medical Xpress

Study of laser treatment supports shift in standard glaucoma care

Glaucoma is a lifelong eye disease that requires regular treatment. For many, it can be controlled by a daily eye drop regimen, but the treatment is not perfect—the preservatives in the drops can ...
Nasdaq

Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...